GYRE THERAPEUTICS, INC. (GYRE) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $170.94M2011: $83.84M2012: $13.66M2013: $11.26M2014: $3.46M2015: $38.10M2016: $22.02M2017: $8.74M2018: $4.97M2019: $30.22M2020: $18.78M2021: $14.57M2022: $12.54M2023: $38.06M2024: $27.00M2025: $23.85M$23.85M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$23.85M-11.7%
2024$27.00M-29.1%
2023$38.06M+203.6%
2022$12.54M-14.0%
2021$14.57M-22.4%
2020$18.78M-37.9%
2019$30.22M+507.4%
2018$4.97M-43.1%
2017$8.74M-60.3%
2016$22.02M-42.2%
2015$38.10M+1002.3%
2014$3.46M-69.3%
2013$11.26M-17.6%
2012$13.66M-83.7%
2011$83.84M-51.0%
2010$170.94M